Clinical Trials Update: Oct. 7, 2009

• Gout
• Schizophrenia
• Parkinson's Disease

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Gout

This study is evaluating an investigational medication for gout when used in combination with another medication.

The research site is in Dallas, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.

-----

Schizophrenia

This 52-week study will evaluate long-acting injectable Aripiprazole. Participants must be 18 to 60 and be diagnosed with schizophrenia.

The research site is in Chandler, Ariz.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/schizophrenia.aspx.

-----

Parkinson's Disease

This study will evaluate the safety and effectiveness of an experimental treatment to reduce motor symptoms in people with advanced Parkinson's disease.

The research site is in Stanford, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/parkinsons_disease.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.